LY3867070

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3867070, covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3867070 in Healthy Participants [Phase 1]